“…This study was part of a series of randomized, placebo-controlled pharmacological experiments (Clos et al, 2018(Clos et al, , 2019 in which dopamine level was manipulated by 2 mg of the D2-antagonist haloperidol. Importantly, such acute low doses of D2-antagonists are thought to preferably block presynaptic D2-autoreceptors (Frank and O'Reilly, 2006;Knutson and Gibbs, 2007;Clos et al, 2018Clos et al, , 2019, which regulate dopamine release (Ford, 2014). Therefore, their blockade potentiates phasic dopamine release (Dugast et al, 1997;Pehek, 1999;Jaworski et al, 2001;Garris et al, 2003;Chen et al, 2005).…”